Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 2.737M
June 30, 2026 -9.693M
March 31, 2026 0.657M
December 31, 2025 1.603M
September 30, 2025 10.08M
June 30, 2025 1.469M
March 31, 2025 10.89M
December 31, 2024 4.193M
September 30, 2024 6.021M
June 30, 2024 -0.534M
March 31, 2024 -21.62M
December 31, 2023 73.00M
September 30, 2023 12.59M
June 30, 2023 17.88M
March 31, 2023 14.86M
December 31, 2022 0.146M
September 30, 2022 22.65M
June 30, 2022 0.203M
March 31, 2022 0.007M
December 31, 2021 1.967M
Date Value
September 30, 2021 13.77M
June 30, 2021 -17.16M
March 31, 2021 337.54M
December 31, 2020 31.69M
September 30, 2020 15.08M
June 30, 2020 16.27M
March 31, 2020 -1.135M
December 31, 2019 18.59M
September 30, 2019 0.1158M
June 30, 2019 0.8109M
March 31, 2019 10.86M
December 31, 2018 -0.0323M
September 30, 2018 19.26M
June 30, 2018 3.216M
March 31, 2018 13.33M
December 31, 2017
September 30, 2017 2.901M
June 30, 2017 6.257M
March 31, 2017 6.975M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 471.00M
Bio-Rad Laboratories, Inc. -1.60M
Bruker Corp. -110.10M
Danaher Corp. -262.00M
Harvard Bioscience, Inc. -0.045M